Submission requirements
See what a reviewer will ask you for.
Pick your product category and target region. This is the evidence structure DSRV works from, section by section, with the regulation or guidance behind every line. No account, no upload, no readiness grade.
Product category
Submission region
Only the regions listed above have a published checklist for medical devices today. Ask DSRV if you need another region.
7 sections · 22 evidence items
Citations are regulatory anchors for orientation, not an exhaustive or binding checklist. DSRV's reviewer confirms applicability to your specific product and submission type.
- Section 01
Device Overview & Classification
- FDA21 CFR 807 — premarket notification; device classification
Device description and intended use
Classification / regulatory pathway rationale
Predicate device comparison (substantial equivalence)
- Section 02
Design Controls
- FDA QSR21 CFR 820.30 — design controls
Design inputs / outputs
Design verification evidence
Design validation evidence
Design history file references
- Section 03
Risk Management
- ISOISO 14971 — application of risk management to medical devices
Risk management file / analysis
Risk-benefit rationale
- Section 04
Performance & Bench Testing
- FDARecognized consensus standards; device-specific guidance
Bench / performance test reports
Biocompatibility evaluation (ISO 10993 series)
Sterilization validation (if applicable)
Shelf life / packaging integrity testing
- Section 05
Software / Cybersecurity (if applicable)
- FDAFDA premarket software & cybersecurity guidance; IEC 62304
Software documentation level + lifecycle evidence
Cybersecurity risk documentation
- Section 06
Labeling
- FDA21 CFR 801 — device labeling
Label copy
Instructions for use
- Section 07
Submission Readiness Review
- DSRVDSRV submission-readiness review gate
Completeness checklist
Missing items
Reviewer comments
Client action items
Readiness status
Nothing here needs a document from you
This list is the starting structure, not a verdict on your programme. Evidence only moves into a private, engagement-scoped workspace after confidentiality scope is agreed, and a DSRV reviewer confirms which items actually apply to your product.